Learn more at Pluvicto-HCP.com. For US health care providers (HCPs) only.
PLUVICTO is a Novartis Pharmaceuticals Corporation brand and is not associated with any individual users on LinkedIn.
To speak with someone at Novartis Pharmaceuticals Corporation, please call +1-844-662-4636.
7/23 201728-1
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.pluvicto-hcp.com
Pluvicto® (Lutetium Lu 177 Vipivotide Tetraxetan) Hcp Questions
Pluvicto® (Lutetium Lu 177 Vipivotide Tetraxetan) Hcp's website is https://www.pluvicto-hcp.com
Pluvicto® (Lutetium Lu 177 Vipivotide Tetraxetan) Hcp's LinkedIn profile is https://www.linkedin.com/company/pluvictohcp
Pluvicto® (Lutetium Lu 177 Vipivotide Tetraxetan) Hcp's industry is
Pharmaceutical Manufacturing
Pluvicto® (Lutetium Lu 177 Vipivotide Tetraxetan) Hcp's top competitors are
Imfinzi® (Durvalumab) Hcp,
Entyvio (Vedolizumab),
Keytruda® (Pembrolizumab) Hcp,
Quviviq® (Daridorexant),
Benlysta (Belimumab),
Tagrisso® (Osimertinib) Hcp,
Tezspire® (Tezepelumab-Ekko) Hcp,
Kisqali Hcp,
Zerbaxa® (Ceftolozane And Tazobactam) Hcp,
Fasenra® (Benralizumab) Hcp.
Pluvicto® (Lutetium Lu 177 Vipivotide Tetraxetan) Hcp's categories are Pharmaceutical Manufacturing
